Hayat Pharmaceutical Industries Co. PLC (ASE:HPIC)
Jordan
· Delayed Price · Currency is JOD 3.360
+0.060 (1.82%)
At close: Apr 27, 2026
ASE:HPIC Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 17.11 | 16.71 | 15.81 | 17.11 | 16.58 | Upgrade
|
| Revenue Growth (YoY) | 2.39% | 5.72% | -7.61% | 3.15% | 0.02% | Upgrade
|
| Cost of Revenue | 7.05 | 7.45 | 5.93 | 6.01 | 5.39 | Upgrade
|
| Gross Profit | 10.06 | 9.26 | 9.88 | 11.09 | 11.19 | Upgrade
|
| Selling, General & Admin | 6.35 | 5.22 | 6.36 | 6.45 | 6.21 | Upgrade
|
| Research & Development | 0.85 | 0.7 | 0.66 | 0.58 | 0.47 | Upgrade
|
| Other Operating Expenses | -0.47 | -0.35 | 0.02 | -0.14 | -0.05 | Upgrade
|
| Operating Expenses | 7.12 | 5.57 | 7.04 | 6.89 | 6.77 | Upgrade
|
| Operating Income | 2.94 | 3.69 | 2.84 | 4.2 | 4.42 | Upgrade
|
| Interest Expense | -0.14 | -0.15 | -0.1 | -0.07 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | 2.81 | 3.54 | 2.74 | 4.14 | 4.33 | Upgrade
|
| Pretax Income | 2.81 | 3.54 | 2.74 | 4.14 | 4.33 | Upgrade
|
| Income Tax Expense | 0.5 | 0.45 | 0.41 | 0.61 | 0.69 | Upgrade
|
| Net Income | 2.31 | 3.09 | 2.33 | 3.53 | 3.64 | Upgrade
|
| Net Income to Common | 2.31 | 3.09 | 2.33 | 3.53 | 3.64 | Upgrade
|
| Net Income Growth | -25.30% | 32.73% | -34.04% | -3.12% | 3.75% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| EPS (Basic) | 0.24 | 0.33 | 0.25 | 0.37 | 0.38 | Upgrade
|
| EPS (Diluted) | 0.24 | 0.33 | 0.25 | 0.37 | 0.38 | Upgrade
|
| EPS Growth | -25.30% | 32.73% | -34.04% | -3.12% | 3.75% | Upgrade
|
| Free Cash Flow | 3.17 | 1.59 | 2.44 | 2.23 | 3.95 | Upgrade
|
| Free Cash Flow Per Share | 0.33 | 0.17 | 0.26 | 0.23 | 0.42 | Upgrade
|
| Dividend Per Share | 0.190 | 0.220 | 0.165 | 0.250 | 0.250 | Upgrade
|
| Dividend Growth | -13.64% | 33.33% | -34.00% | - | 25.00% | Upgrade
|
| Gross Margin | 58.80% | 55.40% | 62.51% | 64.85% | 67.48% | Upgrade
|
| Operating Margin | 17.21% | 22.09% | 17.96% | 24.58% | 26.66% | Upgrade
|
| Profit Margin | 13.49% | 18.49% | 14.73% | 20.63% | 21.96% | Upgrade
|
| Free Cash Flow Margin | 18.50% | 9.50% | 15.45% | 13.07% | 23.80% | Upgrade
|
| EBITDA | 4.16 | 4.79 | 3.93 | 5.26 | 5.32 | Upgrade
|
| EBITDA Margin | 24.33% | 28.70% | 24.84% | 30.73% | 32.09% | Upgrade
|
| D&A For EBITDA | 1.22 | 1.1 | 1.09 | 1.05 | 0.9 | Upgrade
|
| EBIT | 2.94 | 3.69 | 2.84 | 4.2 | 4.42 | Upgrade
|
| EBIT Margin | 17.21% | 22.09% | 17.96% | 24.58% | 26.66% | Upgrade
|
| Effective Tax Rate | 17.72% | 12.67% | 15.07% | 14.68% | 15.91% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.